KP, Y., SL, L., MT, L., JR, V., JL, B., & SD, W. (2006). Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction. British journal of clinical pharmacology, 61(2), 200. https://doi.org/10.1111/j.1365-2125.2005.02540.x
Chicago Style (17th ed.) CitationKP, Yeo, Lowe SL, Lim MT, Voelker JR, Burkey JL, and Wise SD. "Pharmacokinetics of Ruboxistaurin Are Significantly Altered by Rifampicin-mediated CYP3A4 Induction." British Journal of Clinical Pharmacology 61, no. 2 (2006): 200. https://doi.org/10.1111/j.1365-2125.2005.02540.x.
MLA (9th ed.) CitationKP, Yeo, et al. "Pharmacokinetics of Ruboxistaurin Are Significantly Altered by Rifampicin-mediated CYP3A4 Induction." British Journal of Clinical Pharmacology, vol. 61, no. 2, 2006, p. 200, https://doi.org/10.1111/j.1365-2125.2005.02540.x.